Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of Respiratory System I: Upper Respiratory Tract01:29

Anatomy of Respiratory System I: Upper Respiratory Tract

4.5K
The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
4.5K
Nose and Nasal Cavity01:24

Nose and Nasal Cavity

9.7K
The nose is composed of an observable exterior segment (external nose) and an internal segment within the skull known as the nasal cavity (internal nose). The external nose, visible on the face, consists of a framework of bone and hyaline cartilage enveloped in skin and muscle and lined with a mucous membrane. This structure is supported by the frontal bone, nasal bones, and maxillary bone and is supplemented by a cartilaginous framework comprising the septal nasal cartilage, lateral nasal...
9.7K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

584
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
584
Epistaxis01:30

Epistaxis

478
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
478
Chronic Pharyngitis01:23

Chronic Pharyngitis

10.4K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
10.4K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

747
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
747

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role, evaluation, and effects of comorbidities in patients with chronic rhinosinusitis.

The journal of allergy and clinical immunology. In practice·2026
Same author

Remission in Global Airway Diseases: EUFOREA Consensus Paper.

Allergy·2026
Same author

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

The journal of allergy and clinical immunology. Global·2026
Same author

Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry.

Advances in therapy·2026
Same author

The Burden of Chronic Rhinosinusitis Without Nasal Polyps: A Systematic Review of Epidemiological, Clinical, Humanistic, and Economic Evidence.

Advances in therapy·2026
Same author

Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID Registry.

Advances in therapy·2026
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.4K

Nasal polyps and rhinosinusitis.

Jason H Kwah, Anju T Peters

    Allergy and Asthma Proceedings
    |November 7, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Chronic rhinosinusitis (CRS) involves sinus inflammation lasting over 12 weeks. Topical nasal steroids are key for treating nasal polyps, reducing size and improving airflow, with surgery as a last resort.

    More Related Videos

    Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
    04:35

    Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

    Published on: December 27, 2024

    866
    Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
    09:02

    Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

    Published on: September 22, 2023

    2.1K

    Related Experiment Videos

    Last Updated: Jan 4, 2026

    Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
    06:08

    Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

    Published on: September 22, 2023

    2.4K
    Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
    04:35

    Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

    Published on: December 27, 2024

    866
    Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
    09:02

    Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

    Published on: September 22, 2023

    2.1K

    Area of Science:

    • Otolaryngology
    • Immunology
    • Pathology

    Background:

    • Rhinosinusitis, inflammation of paranasal sinuses, affects ~12% of the population.
    • Chronic rhinosinusitis (CRS) is defined by symptoms >12 weeks, with subtypes including CRS with nasal polyps (CRSwNP).
    • Nasal polyps, inflammatory outgrowths, are found in 20% of CRS patients and linked to asthma and AERD.

    Purpose of the Study:

    • To review the definition, causes, and management of rhinosinusitis, particularly CRS with nasal polyps.
    • To highlight the role of inflammation and anatomical factors in CRS pathogenesis.
    • To outline current treatment strategies, including medical and surgical options.

    Main Methods:

    • Literature review of rhinosinusitis definitions, pathophysiology, and treatment modalities.
    • Analysis of the role of ciliary function and sinus drainage pathways.
    • Evaluation of pharmacological and surgical interventions for CRS and nasal polyps.

    Main Results:

    • Acute rhinosinusitis is often viral and self-limiting; bacterial infection is considered if symptoms persist >7-10 days.
    • Topical nasal steroids are the primary treatment for nasal polyps, reducing size and congestion.
    • Surgery is reserved for severe obstruction or medical treatment failure; aspirin desensitization can benefit AERD patients.

    Conclusions:

    • Effective management of CRS, especially CRSwNP, relies on a combination of medical therapies, including intranasal corticosteroids.
    • Understanding sinus anatomy and inflammatory processes is crucial for successful treatment outcomes.
    • Personalized treatment approaches, considering comorbidities like AERD, optimize patient care and reduce the need for surgery.